Skip to Content

SomnoMed Ltd SOMNF

Morningstar Rating
$0.39 −0.05 (12.36%)
View Full Chart
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SOMNF is trading at a 52% discount.
Price
$0.39
Fair Value
$3.85
Uncertainty
Extreme
1-Star Price
$3.21
5-Star Price
$7.64
Economic Moat
Zvv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SOMNF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.44
Day Range
$0.390.39
52-Week Range
$0.390.98
Bid/Ask
$0.29 / $0.30
Market Cap
$38.21 Mil
Volume/Avg
100 / 4,293

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.56
Dividend Yield
Dividend Yield (Forward)
Total Yield

Company Profile

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
22

Valuation

Metric
SOMNF
Price/Earnings (Normalized)
Price/Book Value
2.14
Price/Sales
0.56
Price/Cash Flow
Price/Earnings
SOMNF

Financial Strength

Metric
SOMNF
Quick Ratio
1.13
Current Ratio
1.50
Interest Coverage
−1.68
Quick Ratio
SOMNF

Profitability

Metric
SOMNF
Return on Assets (Normalized)
−11.57%
Return on Equity (Normalized)
−28.50%
Return on Invested Capital (Normalized)
−11.91%
Return on Assets
SOMNF

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesPlvxp$180.6 Bil
SYK
Stryker CorpBydp$109.9 Bil
MDT
Medtronic PLCQxz$105.8 Bil
BSX
Boston Scientific CorpLrwpcr$80.6 Bil
DXCM
DexCom IncFzgd$45.4 Bil
EW
Edwards Lifesciences CorpNwymd$41.4 Bil
ZBH
Zimmer Biomet Holdings IncSdrw$24.5 Bil
PHG
Koninklijke Philips NV ADRCsnnjx$18.1 Bil
ALGN
Align Technology IncFmrkbb$16.6 Bil
PODD
Insulet CorpDkhcvb$13.6 Bil